Skip to content

Evaluation of Metagenomic Sequencing to Determine the Etiology of Infection in Acute leukaemia Patients with Severe Neutropenia and Fever

Evaluation of Metagenomic Sequencing to Determine the Etiology of Infection in Acute leukaemia Patients with Severe Neutropenia and Fever

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035900
Enrollment
Unknown
Registered
2020-08-19
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute leukemia

Interventions

Gold Standard:traditional pathogenic test results or clinical final diagnosis
Index test:mNGS detection

Sponsors

Hematology Hospital of Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute leukemia aged 15 to 65 years old; 2. Sign written informed consent; 3. Patients should meet one of of the following requirements: (1) Patients with mild fever due to granular deficiency and met the following conditions: 1) Severe neutrophil deficiency (ANC7d or is expected to last >7d; 2) Fever (axillary temperature >=37.5 degree C), accompanied by chills; 3) Patients who have not been treated with antibiotics at the time of enrollment; (2) Patients with septic shock; (3) Suspected fungal pneumonia patients who meet the following conditions: 1) Neutrophil deficiency (ANC<0.5x10^9/L) with fever; 2) Empirical treatment with continuous granular deficiency fever and broad-spectrum antibacterial treatment is ineffective for 4-7 days; 3) CT imaging examination has at least one of the following 4 items: dense, well-defined lesions (with or without Halo sign), air crescent sign, cavity, wedge-shaped, segmental or large leaf consolidation,reverse halo sign (i.e. anti-halo sign).

Exclusion criteria

Exclusion criteria: 1. infection; 2. The pathogen has been diagnosed and antibacterial drugs have been used for more than 3 days, such as fungal infection and tuberculosis infection; 3. The amount of samples is insufficient and the quality of samples is unqualified; 4. HIV patients; 5. Pregnant patients; 6. Patients who take part in other clinical trials; 7. Other situations that the researcher thinks are not suitable for joining the group.

Design outcomes

Primary

MeasureTime frame
The sensitivity and specificity of mNGS detection;

Countries

China

Contacts

Public ContactJianxiang Wang

Hematology Hospital of Chinese Academy of Medical Sciences

wangjx@medmail.com.cn+86 13821389157

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026